Evidence map›Paper›PMID 35284646›Full record

ArticleHealth science reports2022

Interleukin-29 profiles in COVID-19 patients: Survival is associated with IL-29 levels.

Zahra Fallah Vastani, Alireza Ahmadi, Mahdi Abounoori, Motahareh Rouhi Ardeshiri, Elham Masoumi, Iraj Ahmadi, Abdollah Davodian, Mohammadreza Kaffashian, Azra Kenarkoohi, Shahab Falahi and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Health science reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Observational
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Zahra Fallah VastaniStudent Research committee, Department of Laboratory Sciences, Faculty of Allied Medical Sciences Ilam University of Medical Sciences Ilam Iran.ORCID https://orcid.org/0000-0001-9369-8011
Alireza AhmadiStudent Research committee, Department of Laboratory Sciences, Faculty of Allied Medical Sciences Ilam University of Medical Sciences Ilam Iran.
Mahdi AbounooriStudent Research Committee, School of Medicine Mazandaran University of Medical Sciences Sari Iran.
Motahareh Rouhi ArdeshiriDepartment of Physiology, School of Medicine Mazandaran University of Medical Sciences Sari Iran.
Elham MasoumiDepartment of Immunology, School of Medicine Ilam University of Medical Sciences Ilam Iran.
Iraj AhmadiDepartment of Physiology, Faculty of Medicine Ilam University of Medical Sciences Ilam Iran.
Abdollah DavodianDepartment of Clinical Immunology Ilam University of Medical Science Ilam Iran.
Mohammadreza KaffashianStudent Research Committee, School of Medicine Ilam University of Medical Sciences Ilam Iran.
Azra KenarkoohiDepartment of Microbiology, Faculty of Medicine Ilam University of Medical Science Ilam Iran.
Shahab FalahiZoonotic Diseases Research Center Ilam University of Medical Science Ilam Iran.
Sanaz MamiDepartment of Immunology, School of Medicine Ilam University of Medical Sciences Ilam Iran.
Sajad MamiDepartment of Laboratory and Clinical Science, Faculty of Veterinary Medicine Ilam University Ilam Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID‐19interferon‐lambdainterleukin‐29SARS‐CoV‐2

Identifiers

PMID35284646
PMCPMC8907560

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.